Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: jerryriti who wrote (900)	7/22/1999 8:41:00 AM
From: lnkennedy	Read Replies (2) \| Respond to of 1728

Great news! Looks like the west coast,U.Cal and now the east coast, NIH are going to be big time research participants. The rest of the research inst. around the country will come on board w/ time, to keep the data flowing in a universally acceptable format. This is not a whole lot different than how DARPA started in the sixties, sharing info will speed the progress. Nice to see AFFX at the focus of this gene research. This will only bode well short and long term, AFFX the platform of choice for Bio research in the next millenium. Thanks for the hot release. Neal

To: jerryriti who wrote (900)	7/23/1999 10:39:00 AM
From: LLCF	Read Replies (1) \| Respond to of 1728

From the AFFX press release: <Affymetrix has developed and intends to establish its GeneChip system as the platform of choice for acquiring, analyzing and managing complex genetic information in order to improve the diagnosis, monitoring and treatment of disease. The Company's GeneChip system consists of disposable DNA probe arrays containing gene sequences on a chip, reagents for use with the probe arrays, a scanner and other instruments to process the probe arrays and software to analyze and manage genetic information.> So they not only want to sell chips, it seems they want to create the standard platform for analyzing and managing the data as well. Interesting. DAK